Women in Cancer Immunotherapy Network Leadership Institute
Seattle on Aug. 19–20, 2019Empowering women in the cancer immunotherapy fieldApply by April 15 to attend this free program.
Call for Comment: SITC Head and Neck Cancer Immunotherapy Guidelines"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)"
Comments due on Sunday, April 14 by 11:59 p.m PST.
Salt Lake City | Toronto | New Orleans
Join Leisha A. Emens, MD, PhD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.
SITC-ONS Joint Session at ONS Congress SITC and Oncology Nursing Society will host a joint session, Checks & Balances: Cancer Immunotherapy for the Advanced Practice Nurse, during ONS Congress on April 10 in Anaheim, Calif.
Inspire the Next Generation of Cancer Immunotherapy Leaders
Advance the science of cancer immunotherapy and help young investigators tackle hurdles facing the field with a gift to the SITC Forward Fund.
Meet-the-Expert Webinar: How to Kick-Start Your Career in the US
Register today for this free webinar to learn strategies and tactics for how to kick-start your career in the US on April 16 from 1–2 p.m. EST.
Explore resources and educational opportunities for cancer patients and those who advocate for them.
Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.
Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.
For those of you in the Philadelphia area, CAR-T and The Rise of the Cellicon Valley Thursday, May 9 and Friday, May 10, 2019 World experts in CAR T-cellular therapy and hematopoietic stem cell transplantation (HSCT) have been assembled to ...
Hi Priscila, Thanks for the info. Sounds like a great opportunity especially for junior faculty. ------------------------------ Mridula George MD Assistant Professor Rutgers Cancer Institute of New Jersey New Brunswick NJ ------------------------- ...
For those who couldn’t attend, can we get a debrief on interesting data that was presented? I am personally interested in thyroid, thymus, mesothelioma- Thanks! NS Sent from my iPhone The information contained in this electronic e-mail transmission ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org